HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals.
Document Type
Journal Article
Publication Date
10-3-2018
Journal
Molecular therapy : the journal of the American Society of Gene Therapy
Volume
26
Issue
10
Inclusive Pages
2496-2506
DOI
10.1016/j.ymthe.2018.08.015
APA Citation
Sung, J., Patel, S., Clohosey, M., Roesch, L., Tripic, T., Kuruc, J., Archin, N., Hanley, P., Cruz, C., Goonetilleke, N., Eron, J., Rooney, C., Gay, C., Bollard, C., & Margolis, D. (2018). HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals.. Molecular therapy : the journal of the American Society of Gene Therapy, 26 (10). http://dx.doi.org/10.1016/j.ymthe.2018.08.015
Peer Reviewed
1
